{"id":"W2754191446","doi":"10.1093/ofid/ofx162.093","title":"Forty-eight-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1","year":2017,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Medicine; Regimen; Internal medicine; Adverse effect; Human immunodeficiency virus (HIV); Drug; Surgery; Pharmacology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008960907,0.000527114,0.0009127189,0.0002158636,0.0003273767,0.0003755286,0.0002229013,0.0004215144,0.001773858],"category_scores_gemma":[0.001104557,0.0002405027,0.0006249425,0.0001212093,0.0003282108,0.0004421314,0.0002101745,0.001040904,0.0004107575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003567777,"about_ca_system_score_gemma":0.0002601048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002275459,"about_ca_topic_score_gemma":0.0002747964,"domain_scores_codex":[0.9995182,0.000226369,0.00003825613,0.00007425718,0.00005948444,0.00008348179],"domain_scores_gemma":[0.9993394,0.0001265929,0.0001856768,0.00009735547,0.00005004223,0.0002008319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6029557,0.03914577,0.06743716,0.0003988094,0.0007448523,0.0005835639,0.0004371252,0.002247699,0.1096347,0.0001808683,0.00200582,0.1742279],"study_design_scores_gemma":[0.0368547,0.6394473,0.2944599,0.00005023278,0.0005584221,0.00074414,0.0001594582,0.003651332,0.02011125,0.0001941144,0.003704274,0.00006483671],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988173,0.000292599,0.0001272487,0.00003006441,0.00001252159,0.00008848269,0.0001265718,0.00001714901,0.0004880854],"genre_scores_gemma":[0.998835,0.0000896788,0.0001297868,0.00005071836,0.00003053219,0.0001182658,0.0002249188,0.000003110309,0.0005180271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001773858,"threshold_uncertainty_score":0.005934179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01257904486496662,"score_gpt":0.2775908882835476,"score_spread":0.265011843418581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}